{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:14:25Z","timestamp":1783779265598,"version":"3.55.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Sarcopenic obesity (SO) imposes a heavy medical burden on both individuals and society, highlighting the importance of early identification and timely intervention. This study aims to construct a clinical prediction model based on machine learning (ML) methods to assist in the early screening of SO. Data from the National Health and Nutrition Survey from 2011 to 2018 were used for model development. The included data were randomly divided into a training set and an internal test set with a ratio of 7:3. Eight ML methods \u2013 logistic regression, decision tree, neural network, K-nearest neighbor, Naive Bayes, support vector machine, extreme gradient boosting (XGBoost), and light gradient boosting machine \u2013 were used to develop the model. The area under the receiver operating characteristic, calibration curves, and decision curve analysis were employed to evaluate the predictive performance of the constructed model. The SHapley Additive exPlanations method was used to illustrate the importance of variables in the model. After feature screening, 7 indicators were used as ML features to construct the model, including hepatic steatosis index, bone mineral content, skeletal muscle mass to visceral area ratio, history of heart failure, atherogenic index of plasma, neutrophil-to-lymphocytes ratio, and serum phosphorus level. The area under the receiver operating characteristic values of logistic regression, decision tree, neural network, K-nearest neighbor, Naive Bayes, support vector machine, XGBoost, and light gradient boosting machine were 0.83 (95% confidence interval [CI]\u2005=\u20050.81\u20130.85), 0.82 (95% CI\u2005=\u20050.80\u20130.85), 0.86 (95% CI\u2005=\u20050.84\u20130.88), 0.86 (95% CI\u2005=\u20050.85\u20130.88), 0.83 (95% CI\u2005=\u20050.81\u20130.85), 0.85 (95% CI\u2005=\u20050.83\u20130.87), 0.88 (95% CI\u2005=\u20050.86\u20130.90), and 0.87 (95% CI\u2005=\u20050.85\u20130.89), respectively, in the training set, and 0.86 (95% CI\u2005=\u20050.83\u20130.89), 0.79 (95% CI\u2005=\u20050.76\u20130.83), 0.83 (95% CI\u2005=\u20050.80\u20130.87), 0.82 (95% CI\u2005=\u20050.79\u20130.86), 0.83 (95% CI\u2005=\u20050.80\u20130.86), 0.85 (95% CI\u2005=\u20050.82\u20130.88), 0.84 (95% CI\u2005=\u20050.81\u20130.88), and 0.85 (95% CI\u2005=\u20050.82\u20130.88), respectively, in the internal test set. Among these models, XGBoost showed the best prediction performance in the training set. The calibration and decision curve analysis curves showed good predictive performance. The XGBoost-based model in this study performed well and combined 7 clinical predictors to help diagnose SO in adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049142","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:25Z","timestamp":1780718485000},"page":"e49142","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Construction and validation of a machine learning model to predict the sarcopenic obesity population"],"prefix":"10.1097","volume":"105","author":[{"given":"Mingrong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Medical Affairs, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People\u2019s Hospital), Qingyuan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Metabolic and Bariatric Surgery, General Surgery Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5776-2703","authenticated-orcid":false,"given":"Zhenfu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Record Management, The Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-024-00550-w","article-title":"Sarcopenia.","volume":"10","author":"Sayer","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"afac220","DOI":"10.1093\/ageing\/afac220","article-title":"Sarcopenia definition, diagnosis and treatment: consensus is growing.","volume":"51","author":"Sayer","year":"2022","journal-title":"Age Ageing"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/cells11010160","article-title":"Multifactorial mechanism of sarcopenia and sarcopenic obesity. Role of physical exercise, microbiota and myokines.","volume":"11","author":"Bilski","year":"2022","journal-title":"Cells"},{"key":"R4-20260711","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000490361","article-title":"Sarcopenic obesity: time to meet the challenge.","volume":"11","author":"Barazzoni","year":"2018","journal-title":"Obes Facts"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","article-title":"Sarcopenic obesity in older adults: a clinical overview.","volume":"20","author":"Prado","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"R6-20260711","doi-asserted-by":"crossref","first-page":"417","DOI":"10.21037\/hbsn-23-175","article-title":"Sarcopenic obesity: recent consensus and clinical implications in patients with chronic liver disease.","volume":"12","author":"Merli","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s13679-024-00571-2","article-title":"Sarcopenic obesity and cardiovascular disease: an overlooked but high-risk syndrome.","volume":"13","author":"Mirzai","year":"2024","journal-title":"Curr Obes Rep"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1016\/j.clnu.2020.03.006","article-title":"Sarcopenic obesity and its association with respiratory disease incidence and mortality.","volume":"39","author":"Petermann-Rocha","year":"2020","journal-title":"Clin Nutr"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"107739","DOI":"10.1016\/j.biotechadv.2021.107739","article-title":"Using machine learning approaches for multi-omics data analysis: a review.","volume":"49","author":"Reel","year":"2021","journal-title":"Biotechnol Adv"},{"key":"R10-20260711","first-page":"2398","article-title":"Artificial Intelligence and machine learning in clinical medicine.","volume":"388","author":"Shibue","year":"2023","journal-title":"N Engl J Med"},{"key":"R11-20260711","first-page":"1","article-title":"National health and nutrition examination survey: plan and operations, 1999-2010.","volume":"56","author":"Zipf","year":"2013","journal-title":"Vital Health Stat 1"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.","volume":"69","author":"Studenski","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"key":"R14-20260711","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest--non-parametric missing value imputation for mixed-type data.","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"e243604","DOI":"10.1001\/jamanetworkopen.2024.3604","article-title":"Sarcopenia and sarcopenic obesity and mortality among older people.","volume":"7","author":"Benz","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12072-021-10258-8","article-title":"Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.","volume":"16","author":"Roh","year":"2022","journal-title":"Hepatol Int"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.32578","article-title":"Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: a longitudinal cohort study.","volume":"76","author":"Sinn","year":"2022","journal-title":"Hepatology"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","article-title":"Sarcopenia and fatty liver disease.","volume":"13","author":"Kim","year":"2019","journal-title":"Hepatol Int"},{"key":"R19-20260711","doi-asserted-by":"crossref","first-page":"155676","DOI":"10.1016\/j.metabol.2023.155676","article-title":"Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.","volume":"147","author":"Polyzos","year":"2023","journal-title":"Metabolism"},{"key":"R20-20260711","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0303-7207(00)00237-9","article-title":"Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor.","volume":"164","author":"Mathews","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"92","DOI":"10.23736\/S0391-1977.16.02563-3","article-title":"Adipose tissue, obesity and non-alcoholic fatty liver disease.","volume":"42","author":"Polyzos","year":"2017","journal-title":"Minerva Endocrinol"},{"key":"R22-20260711","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/nu16030352","article-title":"The association between obesity and reduced weight-adjusted bone mineral content in older adults: a new paradigm that contrasts with the obesity paradox.","volume":"16","author":"De Lorenzo","year":"2024","journal-title":"Nutrients"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/DMSO.S192256","article-title":"Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis.","volume":"12","author":"Sun","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R24-20260711","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/BRS.0b013e31825409d8","article-title":"Lumbar bone mass predicts low back pain in males.","volume":"37","author":"Hoozemans","year":"2012","journal-title":"Spine (Phila Pa 1976)"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s13679-023-00509-0","article-title":"Effects of nutrition and exercise interventions on persons with sarcopenic obesity: an umbrella review of meta-analyses of randomised controlled trials.","volume":"12","author":"Reiter","year":"2023","journal-title":"Curr Obes Rep"},{"key":"R26-20260711","article-title":"Exercise as a metabolic regulator: targeting AMPK\/mTOR-autophagy crosstalk to counteract sarcopenic obesity.","author":"Zhang","year":"2025","journal-title":"Aging Dis"},{"key":"R27-20260711","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00198-024-07163-9","article-title":"Associations between new obesity indices and abnormal bone density in type 2 diabetes mellitus patients.","volume":"35","author":"Deng","year":"2024","journal-title":"Osteoporos Int"},{"key":"R28-20260711","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/ATVBAHA.120.313831","article-title":"Skeletal muscle pathology in peripheral artery disease: a brief review.","volume":"40","author":"McDermott","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-20260711","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/jcb.25077","article-title":"The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease.","volume":"116","author":"Kim","year":"2015","journal-title":"J Cell Biochem"},{"key":"R30-20260711","doi-asserted-by":"crossref","first-page":"zwaf115","DOI":"10.1093\/eurjpc\/zwaf115","article-title":"Evolution of sarcopenia status and risk of incident cardiovascular disease.","author":"Bing","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"R31-20260711","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12916-024-03841-x","article-title":"Changes in sarcopenia and incident cardiovascular disease in prospective cohorts.","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Med"},{"key":"R32-20260711","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.molcel.2025.08.003","article-title":"KIDINS220 and InsP8 safeguard the stepwise regulation of phosphate exporter XPR1.","volume":"85","author":"Wang","year":"2025","journal-title":"Mol Cell"},{"key":"R33-20260711","doi-asserted-by":"crossref","first-page":"e2425824122","DOI":"10.1073\/pnas.2425824122","article-title":"Structure of ATP synthase from an early photosynthetic bacterium Chloroflexus aurantiacus.","volume":"122","author":"Zhang","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-20260711","doi-asserted-by":"crossref","first-page":"106355","DOI":"10.1016\/j.isci.2023.106355","article-title":"Phosphate depletion in insulin-insensitive skeletal muscle drives AMPD activation and sarcopenia in chronic kidney disease.","volume":"26","author":"Andres-Hernando","year":"2023","journal-title":"iScience"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:01:43Z","timestamp":1783778503000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049142","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2026-01-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}